Literature DB >> 11982813

Occult infection of old nonfunctioning arteriovenous grafts: a novel cause of erythropoietin resistance and chronic inflammation in hemodialysis patients.

George M Nassar1, Steven Fishbane, Juan Carlos Ayus.   

Abstract

BACKGROUND: Occult infection of old nonfunctioning arteriovenous grafts (AVGs) is frequent among hemodialysis patients. It is a recognized cause of bacteremia and other infectious complications. Additionally, old nonfunctioning AVGs may be harbingers of other noninfectious complications. The aim of this study was to investigate whether occult infection of old nonfunctioning AVGs is a cause of a chronic inflammatory state in hemodialysis patients.
METHODS: This study was performed in two phases: In the first phase (study 1), 22 patients with clinically proven occult infection of old nonfunctioning AVG were identified, and data on hemoglobin, weekly erythropoietin dose, and albumin levels were collected retrospectively. Comparisons were made between values obtained pre- and post-AVG resection. In the second phase (study 2), we examined whether the presence of a chronic inflammatory state is associated with occult AVG infection in old nonfunctioning AVGs. Twenty hemodialysis patients were identified with chronic inflammatory state based on erythropoietin dose (units/wk)/hematocrit ratio>470, serum albumin <3.3 g/dL, and CRP>25 mg/L. Among these patients, we found eight with old nonfunctioning AVGs. We then performed indium-labeled white blood cell (WBC) scans on the eight patients to screen for occult infection of old nonfunctioning AVGs. The AVGs with positive indium scan were resected and cultured. Data on hematocrit, erythropoietin dosing, serum albumin, ferritin, and CRP were obtained at 2 months following AVG resection and compared to pre-resection values.
RESULTS: In study 1, the 22 patients with occult infection of old nonfunctioning AVG exhibited profound anemia and hypoalbuminemia. Their mean hemoglobin was 9.2 +/- 1.2 g/dL which improved to 11.6 +/- 0.8 g/dL (P < 0.05) 3 months after AVG resection. Their mean serum albumin was 3.3 +/- 0.5 g/dL which improved to 3.8 +/- 0.2 g/dL (P < 0.05) 3 months after AVG resection. Their mean erythropoietin dosages (units/patient/wk) fell from 14,240 +/- 350 to 6,675 +/- 455 (P < 0.05). In study 2, among the 8 patients with chronic inflammatory state and old nonfunctioning AVG, 6 (75%) had positive indium scans and underwent surgical resection that proved bacterial infection. Upon follow-up, the 2-month data showed a remarkable improvement in the following parameters: weekly erythropoietin dose/hematocrit ratio from 622 +/- 137 to 254 +/- 28 (P < 0.05), plasma ferritin values from 690 +/- 126 ng/mL to 247 +/- 42 ng/mL (P < 0.01), and plasma CRP from 56.7 +/- 9.0 to 14.5 +/- 3.8 mg/L (P < 0.01). Serum albumin values also improved from 3.07 +/- 0.08 g/dL to 3.34 +/- 0.14 g/dL (P = 0.13). Percent plasma iron saturation did not appreciably differ from baseline (20.5% +/- 4.4% to 19.8 +/- 1.9%, P = 0.89).
CONCLUSIONS: Occult infection of old nonfunctioning AVG is a common cause of erythropoietin resistance and chronic inflammatory state among hemodialysis patients. Resection of old nonfunctioning AVGs with occult infection is associated with resolution of markers of chronic inflammatory state.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11982813     DOI: 10.1046/j.1523-1755.61.s80.10.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  12 in total

1.  Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study.

Authors:  Tanushree Banerjee; S Joseph Kim; Brad Astor; Tariq Shafi; Josef Coresh; Neil R Powe
Journal:  Am J Kidney Dis       Date:  2014-09-27       Impact factor: 8.860

2.  A Woman with ESRD with Increasing Need for Erythropoietin to Maintain Hemoglobin.

Authors:  Holly M Koncicki; Steven Fishbane
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-18       Impact factor: 8.237

3.  C-reactive protein levels in patients on maintenance hemodialysis: reliability and reflection on the utility of single measurements.

Authors:  Caroline E Stigant; Ognjenka Djurdjev; Adeera Levin
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

4.  Accumulation of retained nonfunctional arteriovenous grafts correlates with severity of inflammation in asymptomatic ESRD patients.

Authors:  Haimanot Wasse; Francesca Cardarelli; Christine De Staercke; W Craig Hooper; Qi Long
Journal:  Nephrol Dial Transplant       Date:  2012-10-22       Impact factor: 5.992

5.  Transplant nephrectomy improves survival following a failed renal allograft.

Authors:  Juan Carlos Ayus; Steven G Achinger; Shuko Lee; Mohamed H Sayegh; Alan S Go
Journal:  J Am Soc Nephrol       Date:  2009-10-29       Impact factor: 10.121

Review 6.  Catheter-related infections in children treated with hemodialysis.

Authors:  Fabio Paglialonga; Susanna Esposito; Alberto Edefonti; Nicola Principi
Journal:  Pediatr Nephrol       Date:  2004-12       Impact factor: 3.714

7.  The initial vascular access type contributes to inflammation in incident hemodialysis patients.

Authors:  Mala Sachdeva; Adriana Hung; Oleksandr Kovalchuk; Markus Bitzer; Michele H Mokrzycki
Journal:  Int J Nephrol       Date:  2011-10-25

8.  "Out of Sight, Out of Mind": The Failed Renal Allograft as a Cause of ESA Resistance.

Authors:  Anita Mehrotra; Judy A Tan; Scott A Ames
Journal:  Semin Dial       Date:  2015-06-21       Impact factor: 3.455

9.  Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness.

Authors:  Angel L M de Francisco; Peter Stenvinkel; Sophie Vaulont
Journal:  NDT Plus       Date:  2009-01

10.  Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial.

Authors:  Sunil V Badve; Lei Zhang; Jeff S Coombes; Elaine M Pascoe; Alan Cass; Philip Clarke; Paolo Ferrari; Stephen P McDonald; Alicia T Morrish; Eugenie Pedagogos; Vlado Perkovic; Donna Reidlinger; Anish Scaria; Rowan Walker; Liza A Vergara; Carmel M Hawley; David W Johnson
Journal:  Can J Kidney Health Dis       Date:  2015-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.